Hanmi/Aptose’s AML Contender Shows Early Promise

Oral Myeloid Kinome Inhibitor Set For Expansion Trials

 
• By Jung Won Shin
  
AML
Hanmi’s AML Candidate Nears Registrational Studies • Source: Shutterstock

More from Anticancer

More from Therapy Areas